T 1853/16 (Combination therapy of breast cancer/GENENTECH) of 07.02.2018
- European Case Law Identifier
- ECLI:EP:BA:2018:T185316.20180207
- Date of decision
- 7 February 2018
- Case number
- T 1853/16
- Petition for review of
- -
- Application number
- 98963840.8
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Treatment with anti-ErbB2 antibodies
- Applicant name
- Genentech, Inc.
- Opponent name
- Generics [UK] Limited (opposition withdrawn)
Dörries, H. Ulrich
Pohlman Patentanwälte Rechtsanwälte PartG mbB
Pfizer, Inc.
Appelt, Christian W.
Taylor Wessing LLP
König Szynka Tilmann von Renesse - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 100(a)European Patent Convention Art 56
- Keywords
- Inventive step - (no)
- Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal is dismissed.